biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by chance18on Sep 12, 2018 2:19pm

110 Views

Post# 28606701

The share price is

a gift I’ve been hearing that for years and buying for years . I hear what you say about M.Day and I agree with you totally . It’s just been so painful year after year to see this little start up company advance in the science and fail in the market . I’m here to make money and thats the bottom line and so far all that’s happened is I’ve lost my money. Being invested in the company with hopes the science can help people in need is the bonus . Let’s see if Mark comes through by the end of the year to ease investors .

Bullboard Posts

Gold, growth and sustainability in focus for Mandalay Resources